Scottsdale Healthcare Is West's Only Clinical Research Site For "Dream Team" Pancreatic Cancer Research Studies

Main Category: Pancreatic Cancer
Also Included In: Cancer / Oncology
Article Date: 01 Jun 2009 - 2:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Scottsdale Healthcare, through its strategic alliance with the Translational Genomics Research Institute (TGen), is one of three clinical research sites in the United States that will participate in a three-year investigation into new approaches to treating pancreatic cancer, the fourth leading cause of cancer death in the U.S.

The clinical trials will be designed to deprive pancreatic tumors of crucial nutrients, thereby cutting off the fuel supply. Understanding the cell's fuel supply will help scientists develop more individualized treatments with fewer side effects.

Scottsdale Healthcare became a primary clinical research site for TGen in 2005, a strategic alliance resulting in creation of TCRS, which is housed in the Virginia G. Piper Cancer Center at Scottsdale Healthcare. Cancer patients from across the U.S. and other countries regularly travel to Scottsdale Healthcare to participate in groundbreaking clinical trials. The Scottsdale Healthcare-TGen alliance facilitates bench-to-bedside application of new research discoveries in patients with advanced cancer.

Other clinical research sites in the study are the University of Pennsylvania in Philadelphia and John Hopkins University in Baltimore.

Source
Scottsdale Healthcare